SHIKARI® Anti-Ipilimumab ELISA w/confirmation (S-ATI)

SHIKARI® Anti-Ipilimumab ELISA w/confirmation (S-ATI)

Catalog Number:
EK01462302MAT
Mfr. No.:
IPI-QNS-YER
Price:
  • Size:
    96 tests
    Quantity:
    Add to Cart:
      • Overview
        • This kit has been especially developed for the quantitative determination of ipilimumab in serum and plasma.

          The Anti-Ipilimumab ELISA Kit can be efficiently used for monitoring anti-Ipilimumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-ipilimumab antibodies. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

          All SHIKARI® ELISA kits are suitable for biosimilar work. All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

          Please contact us at for specific academic pricing.

          More Details

      • Properties
        • Details
          Required Volume (µl): 20
          Total Time (min): 140
          Sample: Serum, plasma
          Sample Number: 96
          Detection Limit (ng/mL): 6.25
          Spike Recovery (%): Between 85-115
          Assay Type: Quantitative
          Species Reactivity: Human
          Storage
          1 year shelf life. Store at +4°C. Please refer to protocols.

          * For Research Use Only

      • Applications
        • Application Description
          Enzyme immunoassay for the quantitative determination of specific antibodies to Ipilimumab(Yervoy®) in human serum and plasma.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
  • Copyright © Amerigo Scientific. All rights reserved.